Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel ETV1 mutation in small cell lung cancer transformation resistant to EGFR tyrosine kinase inhibitors. | Ann Transl Med | 2021 | 34430591 | PubTator, text mining | PubMed |
| High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy. | Sci Rep | 2021 | 34426604 | PubTator, text mining | PubMed |
| ETS1, ELK1, and ETV4 Transcription Factors Regulate Angiopoietin-1 Signaling and the Angiogenic Response in Endothelial Cells. | Front Physiol | 2021 | 34381375 | PubTator, text mining | PubMed |
| Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts. | Nat Commun | 2021 | 34376661 | PubTator, text mining | PubMed |
| KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor. | Mol Cancer Ther | 2021 | 34376580 | PubTator, text mining | PubMed |
| Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer. | Int J Clin Exp Pathol | 2021 | 34367411 | PubTator, text mining | PubMed |
| Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. | Cancers (Basel) | 2021 | 34359682 | PubTator, text mining | PubMed |
| Role of microRNA-129 in cancer and non-cancerous diseases (Review). | Exp Ther Med | 2021 | 34335879 | PubTator, text mining | PubMed |
| Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumors. | PLoS One | 2021 | 34324512 | PubTator, text mining | PubMed |
| Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory. | Nat Immunol | 2021 | 34312544 | PubTator, text mining | PubMed |
| LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro. | Adv Clin Exp Med | 2021 | 34286514 | PubTator, text mining | PubMed |
| Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response. | Cancers (Basel) | 2021 | 34283056 | PubTator, text mining | PubMed |
| Dental-Derived Mesenchymal Stem Cells: State of the Art. | Front Cell Dev Biol | 2021 | 34239870 | PubTator, text mining | PubMed |
| Comprehensive Bioinformatics Analysis of mRNA Expression Profiles and Identification of a miRNA-mRNA Network Associated with the Pathogenesis of Low-Grade Gliomas. | Cancer Manag Res | 2021 | 34234557 | PubTator, text mining | PubMed |
| Re-Evaluate Fusion Genes in Prostate Cancer. | Cancer Inform | 2021 | 34234399 | PubTator, text mining | PubMed |
| The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations. | Front Oncol | 2021 | 34221969 | PubTator, text mining | PubMed |
| Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. | Cancers (Basel) | 2021 | 34208794 | PubTator, text mining | PubMed |
| Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. | Cancers (Basel) | 2021 | 34207428 | PubTator, text mining | PubMed |
| Impact TMPRSS2-ERG Molecular Subtype on Prostate Cancer Recurrence. | Life (Basel) | 2021 | 34205581 | PubTator, text mining | PubMed |
| EWSR1-The Most Common Rearranged Gene in Soft Tissue Lesions, Which Also Occurs in Different Bone Lesions: An Updated Review. | Diagnostics (Basel) | 2021 | 34203801 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=33